Fetal and neonatal alloimmune thrombocytopenia | About the . . . Fetal and neonatal alloimmune thrombocytopenia (NAIT) is a blood disorder that affects pregnant women and their babies NAIT was first reported in the literature in 1953 and is estimated to occur in as many as 1 in 1200 live births
FNAIT Fetal and Neonatal Alloimmune Thrombocytopenia (NAIT) Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT, pronounced “F Nate”), also known as Neonatal Alloimmune Thrombocytopenia (NAIT, “Nate”), is a rare pregnancy-related disorder characterized by a low fetal blood platelet count that affects babies in utero or immediately after birth
Neonatal alloimmune thrombocytopenia - Wikipedia Neonatal alloimmune thrombocytopenia (NAITP, NAIT, NATP or NAT) is a disease that affects babies in which the platelet count is decreased because the mother's immune system attacks her fetus ' or newborn's platelets
Neonatal alloimmune thrombocytopenia (NAIT): An overview Neonatal alloimmune thrombocytopenia (NAIT) is a rare blood disorder that occurs when the maternal immune system attacks the baby's platelets, causing a low platelet count